LeMaitre Vascular Q2 2024 GAAP EPS $0.53 Beats $0.47 Estimate, Sales $55.849M Beat $54.986M Estimate
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular (NASDAQ:LMAT) reported Q2 2024 earnings per share (EPS) of $0.53, surpassing the analyst consensus estimate of $0.47 by 12.77%. The company also reported quarterly sales of $55.849 million, beating the estimate of $54.986 million by 1.57%. This represents an 11.44% increase over the same period last year.
August 01, 2024 | 9:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular (NASDAQ:LMAT) reported Q2 2024 earnings per share (EPS) of $0.53, surpassing the analyst consensus estimate of $0.47 by 12.77%. The company also reported quarterly sales of $55.849 million, beating the estimate of $54.986 million by 1.57%. This represents an 11.44% increase over the same period last year.
LeMaitre Vascular's strong Q2 2024 earnings and sales performance, beating both EPS and revenue estimates, is likely to positively impact its stock price in the short term. The significant year-over-year sales growth further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100